EDGAR Filing Documents for 0001047469-10-003299

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-10-003299

Filing Date

2010-04-05

Accepted

2010-04-05 15:42:30

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2197644zs-3.htm	S-3	308343
2	EXHIBIT 4.17	a2197644zex-4_17.htm	EX-4.17	8910
3	EXHIBIT 5.1	a2197644zex-5_1.htm	EX-5.1	24452
4	EXHIBIT 12.1	a2197644zex-12_1.htm	EX-12.1	18415
5	EXHIBIT 23.1	a2197644zex-23_1.htm	EX-23.1	2892
6	EXHIBIT 23.2	a2197644zex-23_2.htm	EX-23.2	3007
7	EXHIBIT 23.3	a2197644zex-23_3.htm	EX-23.3	2776
8	G70882KGI001.GIF	g70882kgi001.gif	GRAPHIC	205576
9	G70882KGI002.GIF	g70882kgi002.gif	GRAPHIC	80992
	Complete submission text file	0001047469-10-003299.txt		765491

Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725

Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)